At low concentrations, EGCG significantly increased apoptosis in CLL cells involving Bcl-2 down-regulation, caspase 3 activation and the dephosphorylation of VEGF receptors8. This evidence concerns the gene CASP3 and B-cell chronic lymphocytic leukemia.